| Imrinject Kaur Thind, BA | |
|
500 N Bridge St, Bridgewater, NJ 08807-2135 | |
| (908) 725-2800 | |
| (908) 704-1790 |
| Full Name | Imrinject Kaur Thind |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 500 N Bridge St, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144502188 | NPI | - | NPPES |
| 0023701 | Other | NJ | AGENCY MEDICAID PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Imrinject Kaur Thind, BA 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 725-2800 | Imrinject Kaur Thind, BA 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 725-2800 |
News Archive
Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by AstraZeneca LP in connection with its Entocort(R) Enteric Coated Capsules (budesonide), 3mg.
The U.S. Food and Drug Administration today approved Pancreaze Delayed Release Capsules, a pancreatic enzyme product. It is the third such product to receive FDA approval.
Radiation therapy protocol deviations in clinical trials are associated with increased risk of treatment failure and overall mortality, according to a study entitled, "Radiotherapy Protocol Deviations are Associated with Inferior Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials" to be presented today at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston, MA.
In one of the largest studies ever conducted to better understand insurance coverage of obesity treatments, researchers found that three out of four consumers report that they are not covered for necessary, evidence-based obesity treatment services, including access to a registered dietician (72% not covered), medical weight management (77% not covered), bariatric surgery (76% not covered) or FDA-approved obesity drugs (84% not covered).
› Verified 2 days ago
James W Fay Iv, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1065 Rte 22, Suite 3 D, Bridgewater, NJ 08807 Phone: 908-231-0511 Fax: 908-231-1115 | |
Ms. Joanna L. Harrison-smith, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: Catholic Charities Diocese Of Metuchen, 540 Route 22 East, Bridgewater, NJ 08807 Phone: 908-333-2216 Fax: 609-393-1246 | |
Alyce Ruth, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 540 Route 22, Bridgewater, NJ 08807 Phone: 908-722-1881 Fax: 908-704-0215 | |
Nicole Marie Cowan, BS Counselor Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Ms. Reneasha Eliassaint, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 981 Route 22, Bridgewater, NJ 08807 Phone: 908-231-0511 | |
Mrs. Laura R Burns Sr., BS Counselor Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Ms. Joanne D Reilly, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 |